Financhill
Back

Zoetis 10K Form

Sell
7

ZTS
Zoetis

Last Price:
$160.47
Seasonality Move:
3.07%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

Receive ZTS News And Ratings

See the #1 stock for the next 7 days that we like better than ZTS

ZTS Financial Statistics

Sales & Book Value

Annual Sales: $9.3B
Cash Flow: $689M
Price / Cash Flow: 31.76
Annual Sales: $10.64
Price / Book: 15.06

Profitability

EPS (TTM): 5.47000
Net Income (TTM): $2.5B
Gross Margin: $6.5B
Return on Equity: 49.71%
Return on Assets: 17.41%

Zoetis Earnings Forecast

Key Zoetis Financial Ratios

  • The Gross Profit Margin over the past 16 years for ZTS is 70.62%.
  • The Selling, General & Administrative Expenses for ZTS have been equal to 25.04% of Gross Profit Margin.
  • The Research & Development expenses have been 7.41% of Revenue.
  • The Interest Expense is 9.05% of Operating Income.
  • The Net Earning history of ZTS is 26.86% of Total Revenues.
  • Per Share Earnings over the last 16 years have been positive in 14 years.

Zoetis Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: S&P500
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: ZTS
CUSIP: 98978V
Website: zoetis.com

Debt

Debt-to-Equity Ratio: 1.38
Current Ratio: 1.75
Quick Ratio: 0.97

Price-to-Earnings

Trailing P/E Ratio: 29.33
Forward P/E Ratio: 23.52

ZTS Technical Analysis vs Fundamental Analysis

Sell
7
Zoetis (ZTS) is a Sell

Is Zoetis a Buy or a Sell?

  • Zoetis stock is rated a Sell
    The current Zoetis [ZTS] share price is $160.46. The Score for ZTS is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.